Endocrine oncology

Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

Like adults, DRS correctly predicts long-term outcomes in pediatric DTC. In addition to ATA initial risk stratification, DRS could further refine risk in pediatric DTCs and help in planning more personalized treatment and follow-up strategies.

Study context

Population
Children (age ≤18 years) with DTC and follow-up ≥5 years; all had thyroidectomy and radioiodine; median age at diagnosis 15 years
Participants
176 children
Exposure
Dynamic Risk Stratification (DRS) response categories
  • Excellent responsen = 82
  • Biochemical incomplete responsen = 56
  • Structural incomplete responsen = 38
Outcome
Factors affecting disease-free survival (DFS)
Methodological detailsvalidation study
  • Validation study

Main finding

As reported in the abstract

Factors associated with DFS · median follow-up 10.6 years (IQR 7.7-15.5)
Univariate: extrathyroidal extension
P = .002
Univariate: lymph node metastasis
P = .018
Univariate: American Thyroid Association (ATA) initial risk stratification
P = .033
Univariate: DRS
P = .004
Multivariate: DRS alone significantly associated with disease-free survival (DFS)
P = .016

Observational data: associations, not effects.

Further findings

Distribution of DRS response categories · first 2 years of follow-up

Overall survival and DFS · 10 years

10-year overall survival
100%
10-year DFS
88.7%

Original publication

Dynamic Risk Stratification for Predicting Long-term Outcomes in Pediatric Differentiated Thyroid Cancers. J Clin Endocrinol Metab. Published 29 December 2022. doi:10.1210/clinem/dgac731

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.